Issue 140 | March 2024
Biotechs surf obesity drug wave to go beyond GLP-1RAs
In this issue: Studying novel obesity drugs, pharma prepares for climate disasters, the CRISPR pipeline accelerates, exploring drug delivery technologies for the opioid crisis, and more